A drug company is asking Canadian doctors not to use a batch of the H1N1 vaccine that has been found to cause an unusually high number of allergic reactions. The company that made the vaccine, called GlaxoSmithKline, tells NewsChannel 7 none of those doses were sent to the United States.

An FDA spokeswoman tells us that particular vaccine wasn't even licensed for use in the U.S., and they don't know of any similar problems in the U.S. with other companies' vaccines.

According to the Associated Press, in the batch that was recalled, there were just 6 cases of severe allergic reaction out of 170,000 doses. However, they expected there to only be about one or two from a batch that size, so they asked doctors to stop using them. A spokesman for Canada's health minister says there doesn't appear to be a major cause for alarm. He says the reports may be a statistical anomaly.